THC BioMed Intl Ltd. announced that it has appointed Don Shaxon to the company's newly formed Advisory Board. Mr. Shaxon brings 20 years' experience in the capital markets including a successful position as Corporate development Manager with Cannabis Science Inc. where he was instrumental in helping build the company from a small cap company into an industry leader with a market cap that topped $100 million.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.02 CAD | -.--% | -.--% | -.--% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-.--% | 2.41M | |
+42.38% | 6.26B | |
-15.86% | 4.49B | |
+6.36% | 3.29B | |
-11.28% | 3.12B | |
-3.23% | 2.5B | |
+45.24% | 1.94B | |
-7.89% | 1.68B | |
-0.98% | 1.63B | |
-11.32% | 1.56B |
- Stock Market
- Equities
- THC Stock
- News THC Biomed Intl Ltd.
- THC BioMed Intl Ltd. Appoints Don Shaxon to its Advisory Board